Slated keynote speakers are:
Four panels will focus on:
Innovation Trends in Upstream R&D and
A look at pre-competitive consortia of pharma companies, big-data-related methods of generating or capturing chemical and biological diversity, and novel therapeutic modalities such as RNA interference, gene therapy, cell therapy and viral therapy.
Big Data in Healthcare: Where Does That Lead Us?
A look at the wealth of opportunities and challenges brought on by big data, and how players in the healthcare industry are seeking to capitalize on this information to help drive more innovation to improve healthcare outcomes.
Seizing Uncaptured Opportunities in Emerging Markets
Common challenges around regulation, distribution, access, and affordability across diverse emerging markets, as well as innovative approaches in addressing these challenges will be explored.
Transforming Healthcare Entrepreneurship with Innovative Financing
The transformation of the US healthcare system has created a paradigm shift in how start-ups are seeded, grown, and assessed. This panel will encourage discussion on innovative approaches to grow and finance healthcare ventures.
For more information and to register, please visit: http://web.mit.edu/sloanhcc/bioinnovations/2014/.
The MIT Sloan BioInnovations conference has established itself as an important forum for leaders in industry, academia, and policy to discuss current issues and future innovations in the dynamic area of healthcare, from healthcare in emerging markets to new drug technologies. Participants will hear from industry leaders in keynote addresses and panel discussions, will view new technological and business innovations from the many biomedical institutes and startups around
Director of Media Relations
Associate Director of Media Relations